Subsequent studies analysing the role of dopaminergic alterations in MS patients confined to T-cells revealed an association of MS manifestation with the capability of Tregs to produce and respond to dopamine in a DRD5-dependent manner (35). The gene discussed is DRD5; the disease is myeloid sarcoma.